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Oral diseases are major health problems with dental caries and periodontal diseases among the most important preventable global
infectious diseases. Oral health inﬂuences the general quality of life and poor oral health is linked to chronic conditions and
systemicdiseases.Theassociationbetween oraldiseasesandtheoralmicrobiotaiswellestablished.Ofthemorethan750speciesof
bacteria that inhabit the oral cavity, a number are implicated in oral diseases. The development of dental caries involves acidogenic
andaciduricGram-positivebacteria(mutansstreptococci,lactobacilliandactinomycetes).Periodontaldiseaseshavebeenlinkedto
anaerobic Gram-negative bacteria (Porphyromonas gingivalis, Actinobacillus, Prevotella and Fusobacterium). Given the incidence of
oral disease, increased resistance by bacteria to antibiotics, adverse aﬀects of some antibacterial agents currently used in dentistry
and ﬁnancial considerations in developing countries, there is a need for alternative prevention and treatment options that are
safe, eﬀective and economical. While several agents are commercially available, these chemicals can alter oral microbiota and
have undesirable side-eﬀects such as vomiting, diarrhea and tooth staining. Hence, the search for alternative products continues
and natural phytochemicals isolated from plants used as traditional medicines are considered as good alternatives. In this review,
plant extracts or phytochemicals that inhibit the growth of oral pathogens, reduce the development of bioﬁlms and dental plaque,
inﬂuence the adhesion of bacteria to surfaces and reduce the symptoms of oral diseases will be discussed further. Clinical studies
that have investigated the safety and eﬃcacy of such plant-derived medicines will also be described.
1.Introduction
Oral diseases continue to be a major health problem
worldwide [1]. Dental caries and periodontal diseases are
among the most important global oral health problems,
although conditions such as oral and pharyngeal cancers and
oral tissue lesions are also signiﬁcant health concerns [2].
Despite general advances in the overall health status of the
people living in industrialized countries, including oral and
dental health, the prevalence of dental caries in school aged
children is up to 90% and the majority of adults are also
aﬀected [1]. Oral health is integral to general well-being and
relates to the quality of life that extends beyond the functions
of the craniofacial complex. There is a considerable evidence
linking poor oral health to chronic conditions, for example,
there is a strong association between severe periodontal
diseases and diabetes [1–3]. There is also evidence linking
poororalhealthandsystemicdiseases,suchascardiovascular
diseases, rheumatoid arthritis and osteoporosis [4], while
periodontal diseases and may also contribute to the risk of
pregnancy complications, such as preterm low-birth weight
[5]. Tooth loss, caused by poor periodontal health (which
aﬀects up to 20% of the adult population worldwide) can
lead to signiﬁcant morbidity and premature death [2, 3].
The economic impact of oral diseases is an important
consideration with up to 10% of public health expenditure
in developed countries related to curative dental care [3].
In most developing countries, expenditure in oral health
care is low; access to dental healthcare is limited and is
generally restricted to emergency dental care or pain relief
[1]. While there has been a marked improvement in oral
health in most developed countries worldwide, populations
ofdentallydisadvantagedindividualsexistinthesecountries,
often indigenous child populations and those people of low2 Evidence-Based Complementary and Alternative Medicine
socio-economic status, where oral health is deteriorating
[6].
The link between oral diseases and the activities of
microbial species that form part of the microbiota of the
oral cavity is well established [7]. Over 750 species of
bacteria inhabit the oral cavity (∼5 0 %o fw h i c ha r ey e tt o
be identiﬁed) and a number of these are implicated in oral
diseases [7]. The development of dental caries involves aci-
dogenic and aciduric Gram-positive bacteria, primarily the
mutans streptococci (Streptococcus mutans and S. sobrinus),
lactobacilli and actinomycetes, which metabolize sucrose to
organic acids (mainly lactic acid) that dissolve the calcium
phosphate in teeth, causing decalciﬁcation and eventual
decay. Dental caries is thus a supragingival condition [8]. In
contrast,periodontaldiseasesaresubgingivalconditionsthat
have been linked to anaerobic Gram-negative bacteria such
as Porphyromonas gingivalis, Actinobacillus sp., Prevotella
sp. and Fusobacterium sp. [7, 9]. In periodontal diseases,
the areas at or below the gingival crevice become infected
causing a cellular inﬂammatory response of the gingiva
and surrounding connective tissue. These inﬂammatory
responses can manifest as gingivitis (extremely common
and seen as bleeding of the gingival or gum tissues) or
periodontitis (the inﬂammatory response results in loss of
collagen attachment of the tooth to the bone and in loss of
bone) [8].
T h eg l o b a ln e e df o ra l t e r n a t i v ep r e v e n t i o na n dt r e a t m e n t
options and products for oral diseases that are safe, eﬀective
and economical comes from the rise in disease incidence
(particularly in developing countries), increased resistance
by pathogenic bacteria to currently used antibiotics and
chemotherapeutics, opportunistic infections in immuno-
compromized individuals and ﬁnancial considerations in
developing countries [9, 10]. Despite several agents being
commercially available, these chemicals can alter oral micro-
biota and have undesirable side-eﬀects such as vomiting,
diarrhea and tooth staining [11, 12]. For example, bacterial
resistance to most (if not all) of the antibiotics commonly
used to treat oral infections (penicillins and cephalosporins,
erythromycin, tetracycline and derivatives and metronida-
zole) has been documented [13]. Other antibacterial agents
used in the prevention and treatment of oral diseases,
including cetylpyridinium chloride, chlorhexidine, amine
ﬂuorides or products containing such agents, are reported
to exhibit toxicity, cause staining of teeth or in the case
of ethanol (commonly found in mouthwashes) have been
linked to oral cancer [14–18]. Hence, the search for alterna-
tive products continues and natural phytochemicals isolated
from plants used in traditional medicine are considered as
good alternatives to synthetic chemicals [19].
2.TraditionalPlant-BasedMedicines
Medicinal plants have been used as traditional treatments
for numerous human diseases for thousands of years and in
many parts of the world. In rural areas of the developing
countries, they continue to be used as the primary source
of medicine [20]. About 80% of the people in developing
countries use traditional medicines for their health care
[21]. The natural products derived from medicinal plants
have proven to be an abundant source of biologically active
compounds,manyofwhichhavebeenthebasisforthedevel-
opment of new lead chemicals for pharmaceuticals. With
respect to diseases caused by microorganisms, the increasing
resistance in many common pathogens to currently used
therapeutic agents, such as antibiotics and antiviral agents,
has led to renewed interest in the discovery of novel anti-
infective compounds. As there are approximately 500000
plant species occurring worldwide, of which only 1% has
beenphytochemicallyinvestigated,thereisgreatpotentialfor
discovering novel bioactive compounds.
There have been numerous reports of the use of tradi-
tional plants and natural products for the treatment of oral
diseases. Many plant-derived medicines used in traditional
medicinal systems have been recorded in pharmacopeias
as agents used to treat infections and a number of these
have been recently investigated for their eﬃcacy against oral
microbial pathogens. The general antimicrobial activities
of medicinal plants and plant products, such as essential
oils, have been reviewed previously [22, 23]. Therefore, the
purpose of this review is to present some recent examples
from the literature of studies that have served to validate the
traditional use of medicinal plants with speciﬁc biological
activity. In particular, traditional medicinal plant extracts or
phytochemicals that have been shown to inhibit the growth
of oral pathogens, reduce the development of dental plaque,
inﬂuence the adhesion of bacteria to surfaces and reduce the
symptoms of oral diseases will be discussed subsequently. In
addition, clinical studies that have investigated the safety and
eﬃcacy of such plant-derived medicines will be described.
3.Identifying andEvaluatingMedicinal
Pl antP r od uc tsU sedt oT r eato rP r ev e ntO ral
Diseasesof MicrobialEtiology
Of all oral diseases, the incidence of those that have a
microbial etiology is greatest in all parts of the world.
Numerous traditional medicinal plants have been evaluated
for their potential application in the prevention or treatment
of oral diseases. A number of studies have investigated the
activity of plant extracts and products against speciﬁc oral
pathogens, while others have focused on the ability of the
products to inhibit the formation of dental bioﬁlms by
reducing the adhesion of microbial pathogens to the tooth
surface, which is a primary event in the formation of dental
plaque and the progression to tooth decay and periodontal
diseases [24]. Figure 1 illustrates the stages involved in
the development of tooth decay showing the various steps
that can be targeted by antimicrobial plant extracts and
phytochemicals.
4.AntimicrobialAssays
Assays that have been used to test the antimicrobial prop-
erties of medicinal plant extracts and natural products
used to treat or prevent oral diseases involve assessing theEvidence-Based Complementary and Alternative Medicine 3
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Figure 1: The development of tooth decay. (a) Initial adhesin-mediated attachment of mutans streptococci; (b) aggregation mediated
by synthesis of extracellular polysaccharide; (c) metabolism of carbohydrates results in acid production, leading to demineralization and
cavitation of the tooth. Plant extracts and phytochemicals have been demonstrated to inhibit any or all of these stages. That is, cidal activity
against cariogenic bacteria, inhibition of adherence/aggregation/bioﬁlm formation and inhibition of glycolytic acid production.
capacity of the test material to inhibit the growth of typical
oral pathogens, such as Streptococcus sp. (as an example of
bacteria implicated in dental caries) and P. gingivalis (as
an example of bacteria implicated in periodontal diseases).
These tests are usually rapid and can be carried out with
minimal cost. Agar diﬀusion methods (disc diﬀusion or well
diﬀusion) are popular and have been used in a number of
studies [19, 25–30]. These methods involve inoculation of
the surface of an agar plate with the test micro-organism
or pouring molten agar inoculated with the test organism
into a Petri dish. The compound to be evaluated can be
applied on a paper disc or into a well made in the agar. After
appropriate incubation (e.g., in an atmosphere of elevated
CO2 for streptococci), the appearance of zones of growth
inhibition around the disc or well indicates antimicrobial
activity. Other tests can involve simple “spot testing” of
extracts by placing small quantities (10 or 25μL) on the
surface of agar plates containing an overlay of bacteria
and observing inhibition of growth after incubation [9].
Alternative methods involve adsorbing the test compounds
in solution to a solid matrix (e.g., silica gel plates) and then
overlaying with agar containing indicator organisms [9].
The viable count method can be used as an alternative
to agar plate diﬀusion methods. Cultures of bacteria are
centrifuged, washed and resuspended in an appropriate
buﬀer to give a standard concentration of cells. The test
compound is added to the cells, the mixture is incubated and
the number of viable cells is determined by the pour plate
method [11, 12].
Quantifying the antimicrobial activity involves meth-
ods analogous to those used to determine the mini-
mum inhibitory concentration [31] of antimicrobial chem-
ical agents such as antibiotics or disinfectants. This
involves exposing the test organism to serially diluted
extract/compound (either in liquid or solid media) and
determining the minimum concentration that inhibits
growth [9, 10]. These methods are described in ISO 20776
(Clinical laboratory testing and in vitro diagnostic test
systems), which states that “Dilution procedures are used to
determine the minimum inhibitory concentrations (MICs)
of antimicrobial agents and are the reference method for
antimicrobial susceptibility testing. In dilution tests, micro-
organisms are tested for their ability to produce visible
growth on a series of agar plates (agar dilution) or in broth
(broth dilution) containing serial dilutions of the antimi-
crobial agent. The lowest concentration of an antimicrobial
agent that, under deﬁned in vitro conditions, prevents the
appearance of visible growth of a microorganism within a
deﬁned period of time is known as the MIC.”
Time-kill assays are used to determine the time required
for a compound or extract under investigation to eliminate
the growth of the test bacteria [28]. Bacteria are incubated
in an appropriate medium in the presence of test material at
the minimum bactericidal concentration (MBC). At timed
intervals, samples are removed, serially diluted and the
number of surviving bacteria is determined by plating on
agar media. These data are then used to plot time-kill curves.
Bioautography has been used to carry out preliminary
determinations of the number of active constituents in plant
extracts.Thismethodinvolvesseparationoftheextractusing
thin layer chromatography (TLC) and overlaying the TLC
plate with agar inoculated with test bacteria. After appro-
priate incubation, the presence of the zones of inhibition
identiﬁes fractions that contain antimicrobial components
[9, 19]. The use of an indicator that is metabolized into a
colored product by growing bacteria can help to visualize4 Evidence-Based Complementary and Alternative Medicine
the zones of inhibition. For example, using tetrazolium red
results in the zones of inhibition that appear white to yellow
against a red background [9].
5.PlantExtractsandPhytochemicalswith
ActivityagainstOralBacteria
T h e r eh a v eb e e nn u m e r o u sin vitro studies that have inves-
tigated the activity of natural plant substances against oral
bacteria. These studies have focused on bacteria known to
be involved in the etiology of oral and dental diseases. Early
studies have clearly established that a number of substances
had potential to be utilized in the dental industry, given
their activity against cariogenic bacteria and those bacteria
associated with periodontal diseases [32]. Substances that
exhibited activity included spice and herb extracts, such as
cinnamon bark oil, papua-mace extracts and clove bud oil
and constituents of these extracts, such as cinnamic aldehyde
and eugenol [32].
6. AntibacterialActivityof Crude or Total
PlantExtracts
Many studies investigating the activity of traditional medic-
inal plants against oral pathogens have been limited to
examination of crude aqueous or organic solvent extracts. In
most cases, the investigators have simply sought to validate
the traditional medicinal use of the plant. For example, the
use of Drosera peltata (Droseraceae) leaves as a traditional
treatment for dental caries was validated by a study which
showed that chloroform extracts of the aerial plant parts
showed broad spectrum activity a g a i n s tn u m e r o u sb a c t e r i a
of the oral cavity, with greatest activity against S. mutans
and S. sobrinus (MIC = 31.25 and 15.625μgmL −1,r e s p . )
[25]. Plumbagin was identiﬁed as the active component of
this extract. Tichy and Novak [9] investigated a collection
of 27 medicinal and random plants extracts and identiﬁed
a number that inhibited the growth of oral streptococci.
The most active extracts included those from Abies canaden-
sis (Pinaceae), Albizia julibrissin (Fabaceae), Chelidonium
majus (Papaveraceae), Ginkgo biloba (Ginkgoaceae), Junipe-
rus virginiana (Cupressaceae), Pinus virginiana (Pinaceae),
Rosmarinus oﬃcinalis (Lamiaceae), Sassafras albidum (Lau-
raceae), Tanacetum vulgare (Asteraceae) and Thuja plicata
(Cupressaceae). Bioautography indicated that a number
of extracts contained common antimicrobial components,
while other extracts possessed chemically diﬀerent con-
stituents.
A boiling water extract of Coptidis rhizoma (Ranun-
culacea), a traditional Chinese medicinal plant, showed
bactericidal activity against oral bacteria with particularly
good activity against periodontopathogenic bacteria (MIC
= 31–250μgmL −1)[ 33]. Iauk et al. [34] assessed the ability
of 10% decoctions and methanol extracts of a number of
medicinal plants to inhibit bacterial isolates obtained from
crevicular ﬂuid of the periodontal pockets of periodontic
patients. In general, the methanol extracts showed greater
activity than the decoctions. The extract from the leaves of
Hamamelis virginiana (Hamamelidaceae) had the greatest
overall activity against all bacteria tested, with MIC values
generally <512μgmL −1, particularly against Porphyromonas
spp., Preveotella spp. and Actinomyces odontolitycus.
Garlic, Allium sativum (Liliaceae), has been used as a
medicine since ancient times because of its antimicrobial
properties [28]. While garlic has been shown to have activity
against a wide range of bacteria, the speciﬁc activity against
the Gram-negative oral pathogens, including P. gingivalis
has only recently been demonstrated [28]. A garlic extract
containing the major antimicrobial component, allicin,
was active toward Gram-negative pathogens (MIC = 1.1–
17.4mgmL−1) but less active against Gram-positive bacteria
(MIC=35.7–142.7mgmL−1).Theextractalmostcompletely
inhibited trypsin-like protease activity (implicated in the
pathogenesisofperiodontitis)ofP. gingivalis.Takentogether,
theseobservationssuggestthatgarlicextractorallicinmaybe
of therapeutic use against periodontal diseases or other oral
diseases [28].
Harungana madagascariensis (Hypericaceae) is a native
African plant with antimicrobial properties that contains
numerous antimicrobial components [35]. Using successive
Soxhlet solvent extractions, an ethyl acetate extract of leaves
was prepared and tested against numerous oral pathogens.
While the extract was able to kill all oral bacteria tested
(including Actinomyces, Fusobacterium, Lactobacillus, Pre-
votella, Propionibacterium and Streptococcus species), poly
(d,l-lactide-co-glycolide) nanoparticles containing extract
showed enhanced activity. The authors suggested that this
may have been due to the bioadhesive properties of the
polymer resulting in the extract being in contact with the
bacteria for prolonged periods [35].
The resin exuded by the Pistacia lentiscus (Anacar-
diaceae) tree, known as mastic gum, is used in the prepa-
ration of foods and as a remedy for oral malodor and has
been shown to have antimicrobial activity. The activity of
a mastic gum extract against P. gingivalis was demonstrated
using disc diﬀusion assays, but its low solubility suggested
that it may be useful for local application rather than as a
mouthrinse [36]. The antibacterial activity of Pistacia vera
extracts against oral streptococci has also been demonstrated
(MIC > 1mgmL −1), including the inhibition of adherence
and glycolysis [37].
C r u d ee t h a n o le x t r a c t so fPiper cubeba (Piperaceae)
exhibited good antimicrobial properties against a range of
cariogenic pathogens (MIC = 90–200μgmL −1), although no
informationabouttheactivityagainstperiodontalpathogens
was provided [38].
Cold and hot water and ethanolic extracts of Breynia
nivosus (Euphorbiaceae) and Ageratum conyzoides (Aster-
aceae) were tested for activity against S. mutans [30]. While
the hot water and ethanol extracts (at >25mgmL−1)o fB.
nivosus showed activity, none of the A. conyzoides extracts
were active. However, combining the ethanolic extracts of
both plants resulted in synergistic activity. Administration of
250–5000mgkg−1 of B. nivosus extract to mice did not lead
to mortality or produce acute toxicity after 24h.
Smullen et al. [39] determined the ability of commer-
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(PE) of foods with high polyphenol content to inhibit the
growth of S. mutans and other oral pathogens. All the
extracts showed activity, with the PE of red grape seeds
exhibiting the greatest activity against S. mutans (MIC =
500μgmL −1). The green tea and unfermented cocoa PE
were most active against other oral pathogens. Overall, the
commercial extracts were not as active as the PE. Various
PE were also able to prevent adhesion of S. mutans to glass.
These data suggest that extracts of polyphenol-containing
foods may have a preventative role against dental caries.
Helichrysum italicum (Compositae) is widely found in
the Mediterranean region and has been shown to have
a variety of biological properties. An ethanol extract of
powdered ﬂowering tops was found to exert antimicrobial
activity against S. mutans, S. sanguis and S. sobrinus,w i t h
MIC values of 31.25–62.5μgmL −1 [40].
Two recent studies have examined a number of plants
traditionally used in Brazil [41] or South Africa [42],
respectively, for activity against oral pathogens. All four
Brazilian plant extracts, Cocos nucifera (Palmae), Ziziphus
joazeiro (Rhamnaceae), Caesalpinia pyramidalis (Fabaceae)
and Aristolochia cymbifera (Aristolochiaceae), were active
against the test bacteria, with the ethanol extract of A.
cymbiferabeingthemosteﬀective(MIC =0.1–4.0mgmL−1).
Of the South African plants tested, all were eﬀective (MIC
> 25mgmL−1), although the high therapeutic indices deter-
mined for extracts of Annona senegalensis (Ammonaceae),
Euclea natalensis (Ebenaceae) suggested that these may be
safe to administer in vivo.
7. AntibacterialActivityof Propolis
Propolis has been shown to exhibit good antimicrobial
activity against a range of oral bacteria and inhibit the
adherence of S. mutans and S. sobrinus to glass [26]. It was
also shown to be a potent inhibitor of water-soluble glucan
synthesis. In the same study, an extract of Arnica montana
(Asteraceae) demonstrated no antimicrobial activity, nor
did the extract aﬀect adherence or glucan synthesis. Uzel
et al. [43] also investigated the activity of propolis against
a number of microorganisms, including S. mutans and
S. sobrinus. Ethanol extracts of four samples of propolis
collected from diﬀerent geographical regions in Anatolia
exhibited MIC values of 2–64μgmL −1, with activity likely
to be due to the presence of numerous ﬂavonoids. Propolis
showed antimicrobial activity similar to chlorhexidine and
greater than clove or sage extracts in a study investigating the
ability of these chemicals to inhibit the growth of microbes
obtained from the saliva of periodontally healthy subjects
and those with chronic perodontitis [44]. Nidus Vespae, the
honeycomb of Polistes olivaceous (De Geer), P. japonicus
de Saussure and Parapolybiavaria fabricius, is a traditional
Chinese medicine that has a number of pharmacological
properties. While Nidus Vespae is similar to propolis, it
contains additional material including waxes and aromatic
oils. Like propolis, extracts and fractions of Nidus Vespae
have been shown to exert antimicrobial activity toward a
numberoforalmicroorganisms,inparticularS.mutans[45].
In addition, the extracts showed signiﬁcant anti-acidogenic
activity.
8.AntibacterialActivityof Puriﬁed
Phytochemicals
The following section describes the studies of phytochemi-
calsthathavebeenshowntobeactiveagainstoralpathogens.
The studies are grouped according to the general class of
phytochemicals investigated.
8.1. Flavonoids and Other Polyphenols. In a study of a
number of methanolic plant extracts, two active iso-
prenylﬂavones, artocarpin and artocarpesin, were isolated
from Artocarpus heterophyllus (Moraceae). These inhibited
thegrowthofnumerouscariogenicandoralbacteria,includ-
ing mutans and other oral streptococci, actinomyces and lac-
tobacilli,atMICvaluesof3.13–12.5μgmL −1 [46].Flavonone
phytoalexins from Sophora exigua (Leguminosae) have been
showntoinhibitthegrowthofnumerouscariogenicbacteria,
with 5,7,2 ,4 -tetrahydroxy-8-lavandulylﬂavanone being the
most active [47]. Erythrina variegata (Leguminosae) is used
in folk medicine in tropical and subtropical regions and dis-
plays a number of biological properties, including antibac-
terial activity [48]. Seven isoﬂavonoids isolated from the
roots of this plant were tested for their ability to inhibit the
growth of cariogenic oral bacteria. Of these, erycristagallin
showed the most potent inhibitory activity with MIC values
of 1.56–6.25μgmL −1. In addition, erycristagallin completely
suppressed the incorporation of radio-labeled thymidine
and glucose in S. mutans, suggesting that the compound
interferes with bacterial uptake of metabolites [48].
The root bark of Morus alba (Moraceae) has been
used as a traditional medicine in Asian countries and
exhibits antibacterial activity against food poisoning micro-
organisms [11]. Using activity against S. mutans in bioassay-
guided fractionation of a methanol extract of dried root
bark, and organic solvent fractions of this extract, the active
antibacterial constituent was identiﬁed as kuwanon G. The
compounddisplayedanMICof8μgmL −1 againstS.mutans,
which was comparable to chlorhexidine and vancomycin
(1μgmL −1). Time-kill assays indicated that S. mutans was
completely inactivated by 20μgmL −1 kuwanon G within
1min, while testing against other bacteria suggested that
the compound displayed preferential antimicrobial activity
against cariogenic bacteria. Electron microscopic examina-
tion of S. mutans cells treated with kuwanon G indicated that
the mode of antibacterial action was inhibition or blocking
of cell growth, as treated cells showed a disintegrated surface
and an unclear cell margin. A similar mode of antibacterial
action has been reported for the compound isopanduratin A
isolated from Kaempferia pandurate (Zingiberaceae) [49].
A number of components of tea, Camelia sinensis
(Theaceae), exhibit anticariogenic eﬀects through various
modes of action, including bactericidal eﬀects on oral bac-
teria, prevention of adherence of bacteria to tooth surfaces,
inhibition of glucan production and inhibition of amylases
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simple catechins such as epicatechin, epicatechin gallate, and
epigallocatechin gallate are believed to be responsible for
these biological eﬀects [50, 51].
ThepasteoftenderleavesofPsidiumguajava(Myrtaceae)
has been used traditionally to maintain oral hygiene, while
other parts of the plant have various bioactive properties
[19]. A methanol extract of P. guajava leaves was shown to
exhibit inhibitory activity against two strains of S. mutans.
Fractionation guided by bioautography yielded the active
compound, quercetin-3-O-α-l-arabinopyranoside or guai-
javerin, which had MIC values of 2–4mgmL−1.A ts u b - M I C
values, guaijaverin was also able to inhibit acid production of
the test bacteria, decrease the hydrophobicity of one of the
bacteria and inhibit the adherence of both bacteria to glass.
The anti-adherent properties of this plant were supported
by the reduction of cell-surface hydrophobicity observed
in “early settler” plaque bacteria (S. mitis, S. sanguinis and
Actinomyces)e x p o s e dt o1m gm L −1 P. guajava extract [52].
Recently, a proteomics approach was used to show that
treatment of S. mutans with a low concentration (1.6%, v/v)
of a Psidium cattleianum water extract resulted in the down-
regulationofgenesinvolvedinlacticacidproduction,general
metabolism and glycolysis [53]. At higher concentrations
(25–100%, v/v), the extract was able to inhibit S. mutans
bioﬁlms.
Malvidin-3,5-diglucoside (malvin) was identiﬁed as the
active constituent of an ethanol extract of Alcea longi-
pedicellata (Malvaceae) responsible for activity against oral
streptococci, with MIC values of 160–200μgmL −1 [54].
The compound macelignan was isolated from Myristica
fragrans (Myristicaceae) and shown to exert antimicrobial
activity against S. mutans (MIC = 3.9μgmL −1,M B C=
7.8μgmL −1) comparable to chlorhexidine and superior to
other natural anticariogenic agents (sanguinarine, eucalyp-
tol, thymol, menthol and methyl salicylate) [12]. Macelig-
nan (20μgmL −1) displayed rapid antibacterial activity and
completely eliminated viable S. mutans within 1min. It also
showedpreferentialactivityagainstothercariogenicbacteria.
Macelignan also displayed antibioﬁlm activity against S.
mutans, S. sanguis and A. viscosus [55].
The antibacterial activities of an ethanol extract of
the seeds of Piper cubeba were described above. A plant
compound, (−)-cubebin, a naturally found derivative and
three semi-synthetic derivatives were evaluated against a
number of Gram-positive oral bacteria and the yeast Can-
dida albicans [38]. While bacteriostatic and/or fungicidal
activity was observed with all test compounds (although at
levels well above those of chlorhexidine), no information
concerningtheactivityagainstGram-negativepathogenswas
provided.
Naringin, a polymethoxylated ﬂavonoid commonly
found in citrus fruit and an FDA-approved health sup-
plement, was shown to inhibit the growth of periodontal
pathogens and other common oral microorganisms (9.8–
125mgmL−1)[ 56]. Using time-kill assays, naringin was
shown to be particularly eﬀective against Actinobacillus
actinomycetemcomitans and P. gingivalis with signiﬁcant
growth inhibition within 3h and greater inhibition with
increasing incubation time and naringin concentration.
8.2.Terpenes. BakuchiolisolatedfromtheChinesemedicinal
plant, Psoralea corylifolia (Fabaceae), has shown activity
against numerous Gram-positive and Gram-negative oral
pathogens (MIC = 1–4μgmL −1). It was able to inhibit the
growth of S. mutans under a range of sucrose concentra-
tions, pH values and in the presence of organic acids in
a temperature-dependent manner and also inhibited the
growth of cells adhered to a glass surface [57].
Liuetal.[58]puriﬁedsev ennewent-rosanediterpenoids
and a new labdane diterpene from the Chinese medicinal
plant, Sagittaria sagittifolia (Alismaceae). Four of these
compounds (sagittine A–D) exhibited antibacterial activity
against S. mutans and Actinomyces naeslundii (with MIC
values of between 62.5 and 125μgmL −1) while another
(Sagittine E) was only active against A. naeslundii (MIC
= 62.5μgmL −1). Recently, the same group identiﬁed ﬁve
new diterpenoids from Sagittaria pygmaea [59]. None of
these displayed activity against A. actinomycetemcomitans,
while four of the others were active against A. viscosus
and three were active against S. mutans, of Which 18-
β-d-3 ,6 -diacetoxyglucopyranosyl-ent-kaur-16-ene was the
most active (MIC = 15.6μgmL −1).
Curcuma xanthorrhiza (Zingiberaceae) has traditionally
been used to treat a number of disorders. Xanthorrhizol,
isolated from a methanol extract of the plant roots, was
shown to have high levels of antibacterial activity against
oral pathogens, in some cases equal or similar to that of
chlorhexidine, for example MIC against Streptococcus sp. is
equal to 2–4μgmL −1 [60].
8.3. Alkaloids. The alkaloid berberine isolated from C.
rhizoma (Ranunculacea) showed bactericidal activity against
oral bacteria, with greatest activity against A. actinomycetem-
comitans (MIC = 13μgmL −1)a n dP. gingivalis (MIC =
20μgmL −1), although much less activity was observed
againstLactobacillusandStreptococcusspecies.Berberinealso
inhibited the collagenase activity of A. actinomycetemcomi-
tans and P. gingivalis [33].
8.4. Sugar Alcohols. Xylitol is a sugar alcohol naturally found
in plants that is used as an artiﬁcial sweetener in many
foods [61]. Its anticariogenic properties were investigated by
adding 0.78–50% xylitol to broth cultures of S. mutans, S.
saliviarius and S. sanguis, incubating at 37
◦Cf o r1 8 ha n d
determining the optical density of the cultures. Streptococcus
mutans was the only bacterium signiﬁcantly inhibited by
xylitol at 1.56%, while all bacteria showed statistically signif-
icant inhibition at levels above 1.56%. The study concluded
that xylitol exhibited anticariogenic eﬀects by inhibiting the
growth of S. mutans while not aﬀecting other streptococci
that are part of the normal oral ﬂora [61].
8.5. Other Phytochemicals. Several constituents found in
hops, Humulus lupulus (Cannabaceae), have been found to
display antibacterial activity against S. mutans, S. saliviarius
and S. sanguis in disc diﬀusion assays [62] .T h eM I C so fb e t a
acid, xanthohumol (a ﬂavonoid), tetra iso-α acid, iso-α acid
and thymol (a terpene) against S. mutans were determinedEvidence-Based Complementary and Alternative Medicine 7
as 2.0, 12.5, 12.5, 50 and 150μgmL −1, respectively. These
antibacterial activities were enhanced in the presence of
ascorbic acid or when pH was lowered, suggesting that this
eﬀect was the result of the acidic nature of ascorbic acid.
Furthermore, the antibacterial activity of 20% ethanol was
found to increase in the presence of beta acid or thymol.
The antimicrobial properties of a number of commer-
cially available dentifrices containing herbal products have
been evaluated against oral pathogens [63]. The antimi-
crobial eﬀectiveness of the products varied greatly; 10 of
the 14 products showed activity against all test bacteria (S.
mutans, S. sanguis and A. viscosus), but only 6 of these were
able to inhibit the yeast C. albicans. The observations that
some of the dentifrices exhibited no antimicrobial activity
and that some appear to have been contaminated by other
microorganisms were of particular concern.
Thirty-nine natural products were tested for their
antibacterial properties against four strains of S. mutans
and their ability to prevent adherence of the bacteria [10].
Catechol was the most active and inhibited both the growth
(MIC = 6.5μgmL −1) and adherence (>75% inhibition) of
all test bacteria, while emetine hydrochloride and quinidine
sulfate inhibited three of the bacterial strains, but not always
to the same extent as catechol.
9. Investigating Bacterial Adhesion to Surfaces:
Reducing Bioﬁlm and Plaque Formation
Dental plaque is an example of a specialized bacterial bioﬁlm
that develops on the surface of teeth, dental restorations,
prostheses and implants [64]. The colonizing bacteria that
make up the bioﬁlm consortium produce organic acids, such
as lactic acid, by metabolizing carbohydrates that results in
the formation of dental caries [11]. Plaque is also involved
in the etiology of periodontal diseases [65]. A number of
methods have been used to evaluate the potential of natural
products to reduce or eliminate oral bioﬁlms. In contrast
to the methods used to investigate antimicrobial properties
(which involve killing of test bacteria), these methods are
used to assess the ability of the test products to prevent
the adsorption or adhesion of bacteria to surfaces (the
initial stage of bioﬁlm development) or to prevent the
synthesis of the insoluble layer of polysaccharides (fructans
and glucans) by sucrose-dependent fructosyltransferase and
glucosyltransferase activity of the colonizing bacteria (the
second and irreversible stage of bioﬁlm development) [12,
24]. These enzymes split sucrose and transfer the glucose
moiety to a glucose polymer, forming strongly adhesive
extracellular polysaccharides that allow the bacteria to attach
to tooth surfaces [8]. Anti-adhesion agents may be preferable
to those that are bactericidal as selective pressure leading
to resistance and overgrowth of resistant bacteria would be
avoided [24].
Bacterial adhesion can be evaluated by a number of
assays. Radioactively labeled bacteria are added to saliva- or
protein-coated hydroxyapatite (HA) beads in the presence of
the test compound. After incubation, the HA is washed to
remove the loosely bound bacteria and samples counted in a
scintillation counter [24, 65–67]. The adhesion to protein-
coated surfaces can also be investigated using microtiter
plates in which the wells are coated with collagen, human
ﬁbrinogen or human serum and bacteria together with
test material (at diﬀerent concentrations) are added. After
incubation, unbound bacteria are removed by aspiration, the
adherentcellsﬁxedwithmethanol,stainedwithcrystalviolet
and the absorbance at 550nm recorded [29, 66]. Adhesion to
glass surfaces can be assessed in a similar manner [66, 68].
The inhibition of bioﬁlm formation by oral pathogens
has been assessed by cell culture plate assays where bacteria
are incubated in the presence or absence of test compounds
[29, 65]. After appropriate incubation, free bacteria are
removed from microtiter wells by aspiration, bioﬁlms are
stained with crystal violet and the absorbance measured to
indicate the level of bioﬁlm formation. Scanning electron
microscopy has been used to visibly assess the extent of
bioﬁlm formation in the presence and absence of test
material [29]. Alternatively, the inhibitory eﬀects on bioﬁlms
have been assessed by measuring the level of activity of
bacterialenzymessynthesizedduringoralbioﬁlmformation,
speciﬁcally fructosyltransferase and glucosyltransferase [24,
66], or the activity of glucan-binding lectin [66].
10. Plant Extractsand Phytochemicals Which
Inhibit the Adhesion of Oral Bacteria
As a part of some of the studies described above, plants
extracts and phytochemicals were investigated for their
ability to prevent adhesion of cariogenic bacteria to surfaces.
In the following section, studies which have investigated
this activity as a major objective are discussed, even though
antibacterial properties may have also been investigated.
10.1. Anti-Adhesion Activity of Crude or Total Plant Extracts.
Cranberry,Vacciniummacrocarpon(Ericaceae),hasbeenrec-
ognized for its beneﬁcial eﬀects on human health, including
the prevention urinary tract infections by interfering with
adhesion of Escherichia coli to cells and preventing adhesion
of Helicobactor pylori to gastric mucosa [69, 70]. Numerous
studies have investigated the ability of cranberry juice or
cranberryconstituentstopreventadhesionoforalpathogens
to surfaces and related phenomena, such as the production
of glucans and fructans, and the formation of bioﬁlms.
Exposure of oral streptococci to 25% cranberry juice for as
little as 10s has been shown to inhibit adsorption of cells
to saliva-coated hydroxyapatite beads by between 61.8% and
95.1%, with the exception of S. sobrinus for which reduced
adsorption was seen after 10min [65]. In addition, cell
surface hydrophobicity of some of the bacteria was reduced
and a preparation of high molecular weight cranberry juice
constituents inhibited bioﬁlm formation. These data indi-
cated that cranberry juice could prevent dental plaque devel-
opment by inhibiting the initial phase of bioﬁlm formation.
A preparation of high molecular weight cranberry material
was also shown to reduce the activity of fructosyltransferase
and glucosyltransferase [24] and promote the desorption of8 Evidence-Based Complementary and Alternative Medicine
S. sobrinus bioﬁlms, especially those formed by nonsucrose-
dependent adhesion in the absence of polysaccharides [71].
Bacteria pre-exposed to high molecular weight cranberry
material produced thinner bioﬁlms with reduced bacterial
density. Similar results were obtained with P. gingivalis,i n
that a high molecular weight cranberry fraction inhibited
bioﬁlm formation while not aﬀecting growth and viability
of bacteria [29]. At concentrations of 62.5μgmL −1 and
higher,thefractionsigniﬁcantlyinhibitedbioﬁlmformation,
yet no eﬀect on bacterial growth or bioﬁlm viability was
apparent with concentrations up to 250μgmL −1.H o w e v e r ,
this treatment did not result in bioﬁlm desorption. The
speciﬁc inhibitory eﬀect of cranberry juice on S. mutans
bioﬁlm formation has been suggested to be related to the
inhibition of glucan-related processes (inhibition of gluco-
syltransferase, blocking of bacterial adhesion mediated by
surface glucans and reduction of insoluble glucan content)
[70]. Recently, the cranberry juice constituents active against
S. mutans bioﬁlms have been identiﬁed as polyphenols,
speciﬁcally proanthocyanidins and ﬂavonols [72].
In vitro experiments showed that cacao bean husk extract
markedly reduced the growth rate (69–72% reduction)
and inhibited insoluble glucan synthesis of S. mutans and
sucrose-dependent adhesion of S. mutans and S. sobrinus
to a glass surface (85% inhibition at >5mgmL −1)[ 73]. In
addition, in vivo experiments in pathogen-free rats infected
with these bacteria indicated that the extract exhibited
signiﬁcant cariostatic activity.
Twomethods,adherencetoglassandadherencetosaliva-
coated hydroxyapatite (S-HA), were used to assess the eﬀect
ofethanolextractsofsixplantsontheadherenceofS.mutans
[66]. Extracts of Andrographis paniculata (Acanthaceae),
Cassiaalata(Leguminosae),Camelliasinensis,Psidiumguava
and Harrisonia perforata (Simaroubaceae) were able to
inhibit one or both strains of S. mutans tested using
both methods, although relatively high concentrations were
required (MIC50 values of 3–5mgmL−1). Overall, the active
extracts were less eﬀective in inhibiting adhesion to S-
HA than to glass, suggesting that salivary glycoproteins
are important in bacteria-surface interactions, leading to
stronger adherence to S-HA. Camellia sinensis extract exhib-
ited the greatest inhibition of glucosyltransferase activity
while Andrographis paniculata extract showed greatest inhi-
bition of glucan-binding lectin activity of both strains.
As mentioned above an ethanol extract of Helichrysum
italicum (Compositae) powdered ﬂowering tops was found
to exert antimicrobial activity against S. mutans, S. sanguis
and S. sobrinus [40]. At sub-MIC levels (<31.25μgmL −1),
the extracts were able to reduce cell surface hydrophobicity,
adherence to glass and cellular aggregation of S. mutans in
the presence of dextran.
Plants of the genus Mikania (Asteraceae) are used
medicinally in Brazil because of their numerous pharma-
cological properties. Extracts and fractions of the aerial
parts of Mikania laevigata and M. glomerata have been
shown to inhibit the growth of mutans streptococci (MIC =
12.5–100μgmL −1) and sucrose-dependent adherence of
cells to a glass surface [68]. Analysis of the hexane frac-
tion of the extracts, which displayed the most potent
activities, indicated that the active components have nonpo-
lar characteristics.
Methanol extracts of the roots of Polygonum cuspidatum
(Polygonaceae), traditionally used in Korea to maintain oral
health, were shown to reduce the viability of S. mutans and S.
sobrinus (MIC = 0.5–4 mgmL−1), as well as inhibit sucrose-
dependent adherence, water-insoluble glucan formation,
glycolytic acid production and acid tolerance [74]. The
authors suggested that inhibitory eﬀects may be mediated by
thepresenceofalkaloids,phenolicsandsterol/terpenesinthe
extract.
Aqueous and methanol extracts of cloves from Syzygium
aromaticum (Myrtceae) were shown to aﬀect the cariogenic
properties of S. mutans, as exhibited by the ability of the
extracts to inhibit adhesion of the bacteria to glass, reduce
cell surface hydrophobicity and inhibit the production of
glucosyltransferase [75]. While some diﬀerences in the
activities of the aqueous and solvent extracts were observed,
overall this study showed that the two extracts were equally
eﬀective.
Crude aqueous extracts of Piper betle, a plant used
traditionally in the control of dental and oral diseases in
South East Asia, have been shown to inhibit the growth,
adherence and glucan production of S. mutans [76]. Further
studies showed that acid production was also inhibited,
while microscopic examination of bacterial cells exposed
to extract showed cells with “nucleoid material coagulated
into thick electron-dense ﬁlaments and destruction of the
plasma cell membrane and inner cell wall” which was
more apparent with higher extract concentrations [77].
Bioautography identiﬁed one major phenolic constituent as
the antimicrobial component of the extract [77].
10.2. Anti-Adhesion Activity of Puriﬁed Phytochemicals. An
investigation of the eﬀects of macrocarpals (phloroglucinol-
sesquiterpene-coupled compounds) extracted from euca-
lyptus leaves on periodontopathic bacteria demonstrated
that these compounds were able to inhibit the growth of
the majority of bacterial strains tested [67]. Porphyromonas
gingivalis was the most sensitive bacterium with an MIC of
1μgmL −1 for macrocarpals A and B, and 0.5μgmL −1 for
macrocarpal C. In addition, all three compounds were able
to inhibit the expression of P. gingivalis proteases and the
binding of cells to S-HA by 70–80% at a concentration of
10μgmL −1.
As mentioned above, xanthorrhizol has been shown
to inhibit the growth of oral pathogens. The ability of
xanthorrhizol to inhibit bioﬂims of S. mutans has also been
investigated [78]. Using 4-, 12-, 20- and 24-h old bioﬂims,
the greatest level of inhibition was observed at the adherent
(4h) stage (complete inhibition at concentrations of 5, 10
and 50μmoll−1). In older bioﬁlms, 76% inhibition was
achieved with 50μmoll−1 and an exposure time of 60min.
The activities of plant extracts and phytochemicals
detailed in the sections above do not necessarily indicate
that all of these products will have clinical value. In fact,
many of the products are eﬀective only at relatively high
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Table 1: Plant extracts and phytochemicals with potential application against oral bacteria.
Extract (solvent) MICa Reference Phytochemical (class) MICa Reference
Propolis (ethanol) 2.0–64.0 [43] Macrocarpals A,B,C (terpenes) 0.5–1.0 [67]
Mikania laevigata (ethanol) 12.5–100.0 [68] Bakuchiol (terpene) 1.0–4.0 [57]
Mikania glomerate (ethanol) 12.5–100.0 [68] Erycristagallin (ﬂavonoid) 1.6–6.3 [48]
Drosera peltata (chloroform) 15.6–31.3 [25]B e t a a c i d 2 . 0 [ 62]
Helichrysum italicum (ethanol) 31.3–62.5 [40] Xanthorrhizol (terpene) 2.0–4.0 [60]
Coptidis rhizoma (water) 31.0–250.0 [33] Artocarpin (ﬂavonoid) 3.1–12.5 [46]
Piper cubeba (aqueous ethanol) 90.0–200.0 [38] Artocarpesin (ﬂavonoid) 3.1–12.5 [46]
Macelignan (ﬂavonoid) 3.9 [12]
Catechol (phenolic) 6.5 [10]
Kuwanon G (ﬂavonoid) 8.0 [11]
Xanthohumol (ﬂavonoid) 12.5 [63]
Tetra iso-alpha acid 12.5 [62]
Berberine (alkaloid) 13.0–20.0 [33]
Compound 2b (terpene) 15.6 [59]
Chlorhexidinec 1.0 [49]
Triclosanc 0.1–20.0 [80]
aMinimum inhibitory concentration (μgmL −1); b18-β-d-3 ,6 -diacetoxyglucopyranosyl-ent-kaur-16-ene; cThe MIC values for chlorhexidine and triclosan
have been added for comparative purposes.
that strict criteria should be used to assess the potential
application of natural products. In the context of anti-
infective agents, MIC levels of <100μgmL −1 are indicative
of useful bioactivity for natural product extracts. Numer-
ous studies have compared active compounds to currently
used antibacterial compounds used in dentistry, such as
chlorhexidine and triclosan, as a way of determining relative
eﬀectiveness. The MIC of chlorhexidine is ∼1μgmL −1 [49]
whiletriclosanhasanMICof0.1–20μgmL −1 [80].Usingthe
abovecriteria,extractswithMICvaluesof≤100μgmL −1 and
isolated phytochemicals with MIC values of ≤20μgmL −1
maybeconsideredusefulforthedevelopmentasproductsfor
application against oral infections. These are listed in Table 1
and their speciﬁc applications in the prevention or treatment
of oral infections (i.e., antibacterial or antiplaque properties)
are summarized in Figure 2.
10.3. Essential Oils with Activity against Oral Bacteria. The
antibacterial properties of essential oils are well-known and
activity against bacteria found in the oral cavity, including
pathogens, has been documented [23]. Indeed, there is
evidence that commercial mouthwashes containing essential
oils are useful in the long-term control of plaque and mild-
to-moderate gingivitis and are preferred to those containing
chlorhexidine for long-term daily use [81, 82]. A number of
recent studies add to the evidence that essential oils may be
suitable additives in products used for the maintenance of
oral hygiene or prevention of dental disease.
The essential oil of Melaleuca alternifolia (Myrtaceae),
known as tea tree oil (TTO), has been used medicinally for
many years. TTO has antimicrobial properties and is used in
the superﬁcial treatment of skin infections. The activity of
TTO against an extensive collection of oral bacterial isolates
wasinvestigatedbyHammeretal.[31]whodeterminedMIC
and MBC values in the range 0.003–2.0% (v/v). Further,
time-kill assays showed that exposure of S. mutans and
Lactobacillus rhamnosus to 0.5% (v/v) TTO resulted in >3
log reduction of viable cells within 30s. The activity of TTO
against oral pathogens was supported in a study involving
thisandotheressentialoils,includingmanukaoil,eucalyptus
oil,lavandulaoilandrosmarinusoil[83].Inadditiontotheir
inhibitory and bactericidal activities, most of the oils were
able to inhibit the adhesion of S. mutans and P. gingivalis.
Essential oils are also capable of enhancing the activity of
chlorhexidine. When used in combination, the essential oils
of cinnamon and manuka were able to signiﬁcantly reduce
the amount of chlorhexidine required to inhibit the growth
of oral pathogens [84]. This enhanced activity was also
seen against bacterial cultures grown as bioﬁlms. Between
4- and 10-fold reductions of the amount of chlorhexidine
required to inhibit bioﬁlm bacteria was observed when used
in combination with cinnamon, manuka and Leptospermum
morrisonii oils.
The essential oils of Artemisia lavandulaefolia (Aster-
aceae), A. capillaries, A. scoparia and A. feddei have been
shown to inhibit the growth of oral bacteria [85–87],
with the greatest activity generally observed against obligate
anaerobes. However, the oils also showed strong activity
against other groups, including facultative anaerobes and
microaerophilic bacteria. A recent study reported that the
essential oil of Cryptomeria japonica (Taxodiaceae) exhibited
strong activity against all bacteria tested, especially oral
bacteria, with MIC of 0.025–0.5mgmL−1 [87].
While these in vitro results are very encouraging, the
known toxicity of TTO when ingested [88] suggests that
further studies of the safety of this and other essential oils10 Evidence-Based Complementary and Alternative Medicine
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Figure 2: Potential application of plant extracts (a) and phytochemicals (b) in the prevention and treatment of oral diseases caused by
cariogenic and periodontal microbial pathogens. Where known, the likely uses of extracts and phytochemicals are indicated with respect to
their target pathogens (solid arrows) and biological activities (dashed arrows).
foruseintheoralcavityneedtobeaddressed.Inthiscontext,
Takaradaetal.[83]showedthattheessentialoilsusedintheir
study had little eﬀect on human umbilical vein endothelial
cells in vitro when tested at a concentration of 0.2% (v/v),
well within the MIC and MBC values of several oils against
some of the bacteria tested.
11.In Vivo Testing of Dental Products
ContainingPlant-DerivedChemicals
The majority of the studies described above have involved
in vitro assessment of plant extracts and chemicals against
oral pathogens. While these studies provide important
information about the potential use of these products, the
studies described below have examined their in vivo eﬃcacy
in human clinical trails.
In a one group time series design and single blind
study, a mouthrinse containing an extract of the leaves of
Streblus asper (Moraceae) tested in 30 volunteers resulted in
a signiﬁcant (P<. 05) and selective reduction in salivary S.
mutans (assessed by determining the viable bacterial counts
in saliva samples) with no eﬀect on total salivary bacteria
[89]. Moreover, no eﬀect on salivary pH and buﬀer capacity
was observed. Similarly, a randomized placebo-controlled
clinical study of a mucoadhesive dental gel containing
an extract of Azadirachta indica (Meliaceae) involving 36
participants showed a signiﬁcant reduction (P<. 05) in
salivary S. mutans and Lactobacillus sp. bacterial counts after
6 weeks (test group) compared to the placebo group, which
was greater than the reduction seen with a chlorhexidine
mouthwash (positive control group) [90]. A signiﬁcant
reduction in plaque index was also observed (P<. 05).
In vivo evaluation of a 2.5% garlic mouthwash using 30
subjects indicated that the solution was able to maintain
a reduced level of oral bacteria and mutans streptococci 2
weeks after use, although adverse eﬀects such as unpleasant
taste, halitosis and nausea were reported [91]. This 5-week
study measured bacterial levels at baseline (Week 1), and the
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as a mouthwash (Week 2), a garlic mouthwash (Week 3)
and in the following 2 weeks. A signiﬁcant diﬀerence (P<
.05) from baseline levels of bacteria was observed only for
the period following treatment (the residual eﬀect) and not
during the treatment (garlic mouthwash) period.
A randomized placebo-controlled study in which two
commercial tea extracts were used as mouthrinses showed
that each was able to signiﬁcantly reduce the microbial load
oftheoralcavity[92].Asigniﬁcantreduction(P<. 05)inthe
number of bacteria per milliliter of liquid expectorated 5 and
60 min after gargling for 60sec was observed. Combining the
extracts with the surfactant lauryl sodium sulfate resulted in
a potentiation of antimicrobial action, probably as a result of
the combined eﬀects of the surfactant and tea polyphenols
on microbial cell walls and membranes.
A randomized controlled study utilizing a single-blind
cross-over design involving 29 participants demonstrated
that twice daily rinsing with an essential oil-containing
mouthrinse led to signiﬁcant reductions (P<. 01) in total
recoverable streptococci and total recoverable S. mutans (70
and 75%, resp.) in interproximal plaque. Saliva samples also
showed signiﬁcant reductions in the recoverable levels of
total streptococci and S. mutans (P<. 001 and P = .012,
resp.) [93].
Asingle-blind,randomizedcross-overstudyinvolving15
volunteers demonstrated that chewing sticks from Salvadora
persica had similar eﬀects on the levels of subgingival plaque
microbiota as regular toothbrushing without toothpaste
[94]. However, the level of A. actinomycetemcomitans was
signiﬁcantly reduced (P<. 05) by the use of chewing
sticks. In a similar study investigating a commercial herbal
mouthwash containing Salvadora persica extract, signiﬁcant
reductions (P<. 01) in gingival bleeding were observed
in both test and placebo subjects. However, a signiﬁcant
reduction (P<. 05) in the carriage of cariogenic bacteria was
observed only in the test subjects [95].
The eﬃcacy of a hydroalcoholic extract (HAE) of
pomegranate, Punica granatum (Punicaceae), in the pre-
vention of dental plaque was investigated in a randomized
controlled study involving 60 participants who were ran-
domized into three groups: HAE, chlorhexidine (positive
control) or distilled water (negative control) [96]. Dental
plaque material was collected from each participant before
and after a 1-min mouth rinse with the speciﬁed material
and the number of viable bacteria determined by a standard
plate count method. A signiﬁcant reduction in bacteria
was observed in the HAE and chlorhexidine groups (P<
.0001) compared to the control group (distilled water). The
activity of HAE was maintained for at least an hour. The
authors concluded that pomegranate extract could be useful
in the prevention of diseases caused by plaque bacteria.
These results are supported by an in vitro study of a
phytotherapeutic gel containing P. granatum plant powder
[97], which was able to inhibit the adherence of S. mutans,
S. mitis and S. sobrinus (as well as C. albicans) to glass in the
presence of sucrose.
While these studies demonstrate the potential in vivo use
of plant extracts in maintaining oral hygiene, a randomized
controlled study of two herbal mouthrinses containing
extracts of Juniper communis (Cupressaceae), Urtica dioica
(Urticaceae) and Achillea millefolium (Asteraceae) using
subjects with moderate gingival inﬂammation found no
clinically measurable eﬀect on plaque growth (P = .325)
and gingival health (P = .723), despite the fact that in
vitro tests showed weak antimicrobial activity against oral
pathogens[98].Inaddition,astudyinvolving15participants
in a Phase I trial and 17 participants in a Phase II trial of a
novel mouthrinse containing essential oils and extracts from
Melaleucaalternifolia,Leptospermumscoparium(Myrtaceae),
Calendula oﬃcinalis (Compositae) and Camellia sinensis
showed that while the mouthrinse was generally well-
tolerated and not associated with adverse events, it did not
produce a statistically signiﬁcant reduction in the abundance
of oral pathogens [99].
12.SafetyIssuesRelated to Phytomedicines
Used inDentistry
The clinical studies reviewed above have generally assessed
the eﬃcacy of products containing plant-derived products.
However,thesafetyandpossibleside-eﬀectsofsuchproducts
must also be considered. Indeed, these issues have recently
been reviewed by Groppo et al. [100] in relation to natural
products used in dentistry. In agreement with other studies
of the clinical use of natural products, these authors have
concluded that there is limited information available about
the quality, safety and eﬃcacy of herbal products used
in dentistry. Given the possibility of adverse interactions
between herbal formulations with conventional drugs, cau-
tion should be exercised when using herbal medicines and
the need for more clinical studies is recommended. This
review also considered the use of herbal products in other
aspects of dentistry, including as endodontic irrigants, anti-
inﬂammatory agents and those with sedative and anxiolytic
activities.
13. Conclusions
As demonstrated by the examples included in this review,
there is considerable evidence that plant extracts, essential
oils and puriﬁed phytochemicals have the potential to be
developed into agents that can be used as preventative or
treatment therapies for oral diseases. While it is encouraging
to see a number of clinical trials of such products, further
studies of the safety and eﬃcacy of these agents will
be important to establish whether they oﬀer therapeutic
beneﬁts, either alone or in combination with conventional
therapies, that can help to reduce the overall burden of oral
diseases worldwide. In particular, studies that address issues
such as adequate statistical power, blinding, standardization
ofextractsorpuriﬁedcompounds,andqualitycontrolwould
be of great value.
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